Develops and manufactures digital imaging solutions for industrial, medical, and scientific applications. Now — the numbers.
The biggest line carries real weight, but it doesn’t decide everything on its own.
This is an established company with proven profits.
Average growth of 7% a year over the last 4 years. Every year shown ended in profit.
The gap is $2.3B. In times of high interest rates, a gap like that can squeeze a company.
The market pays 31.3× for every dollar of annual profit — around what a business like this usually costs.
Against companies in its own sector, it looks cheaper than 55% of them.
Analysts' average target sits 15% above today's price.
The stock trades below its recent peak — about 13% off the top. A pullback, not a collapse.
It met or beat analyst expectations in 8 of the last 8 quarters — consistency is a promise kept.
Our checks did not surface a specific risk to flag here. That is not the same as there being none.
On our five-subject report card, TDY sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”
The takeaway: TDY is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s what that quality should cost.
Analysts’ average target sits above today’s price, yet the valuation grade (55/100) says the stock isn’t cheap.